Development of ocular hypertension and persistent glaucoma after intravitreal injection of triamcinolone. - sprookjes - yvandenbroek - TriplyDB

Development of ocular hypertension and persistent glaucoma after intravitreal injection of triamcinolone.

Development of ocular hypertension and persistent glaucoma after intravitreal injection of triamcinolone.

http://www.wikidata.org/entity/Q37233253

about

Comparison of dexamethasone intravitreal implant and intravitreal triamcinolone acetonide for the treatment of pseudophakic cystoid macular edema in diabetic patients.Intravitreal versus subtenon triamcinolone acetonide injection for diabetic macular edema: a systematic review and meta-analysis.Prevalence of comorbid retinal disease in patients with glaucoma at an academic medical center Secondary glaucoma in CAPN5-associated neovascular inflammatory vitreoretinopathy.Patients treated with intravitreal triamcinolone acetonide.Looking forward to another exciting year of Clinical Ophthalmology.Response to correspondence from Gallenga and Lobefalo Re: Patients treated with intravitreal triamcinolone acetonide.Endoilluminator-assisted pediatric cataract surgery with hazy cornea

P2860

Q34238856-2AC6204E-BD6A-40A5-9559-CB476D6C34B4 Q34336983-B45921C7-1179-43CE-AF16-7DD149EA8968 Q35867717-397069F2-57E1-4BFB-8626-790F8CC8ECA3 Q36070702-AEB0AD33-E876-4E82-8269-8AD11AF715BA Q37221534-8FD5F950-7A76-415D-9C30-C109412020C5 Q41353086-6FB4188A-E979-403B-8B8A-8FB76B0858B1 Q41585851-1398F527-BD7C-4F5A-B107-8CC68358D745 Q58806272-7EE377E8-14E6-463B-A0A7-C70E49D3A930

P2860

Development of ocular hypertension and persistent glaucoma after intravitreal injection of triamcinolone.

http://www.wikidata.org/entity/Q37233253

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on March 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Development of ocular hyperten ...... al injection of triamcinolone.

@en

Development of ocular hyperten ...... al injection of triamcinolone.

@nl

type

label

Development of ocular hyperten ...... al injection of triamcinolone.

@en

Development of ocular hyperten ...... al injection of triamcinolone.

@nl

prefLabel

Development of ocular hyperten ...... al injection of triamcinolone.

@en

Development of ocular hyperten ...... al injection of triamcinolone.

@nl

P1433

Q37233253-0C14B7FD-DBAD-4FB6-8E09-27F81EC39D5F

P1476

Q37233253-2959E8C2-2CBA-4C8B-B671-3DD226C79B15

P2093

Q37233253-01DE970D-215C-45CF-8136-73CEFA47B909

Q37233253-260E570F-F1C7-4E2C-BC53-483D6DAE5FFD

Q37233253-37FDFD4F-7200-472B-A1B8-52AEFB4F2C8D

Q37233253-731CB402-7B43-491A-8440-04C531FAC1F7

Q37233253-89E2A876-59F8-4555-988D-3D59BDAA10F1

P2860

Q37233253-32A0A331-91AB-4D20-B895-3747BC08A31F

Q37233253-3A7412DE-E837-4CC2-8D88-7E1AA51BC2F6

Q37233253-49B25281-F7C9-4217-8082-CC327E7F8632

Q37233253-51D58DBA-ECB1-4145-81D2-7BC4E36085D4

Q37233253-541955D3-09ED-4464-A1AE-4709BF2F73D6

Q37233253-5EFAD8BE-5365-45A5-8BE3-DB83368682CE

Q37233253-67622761-EBD6-4762-A40B-1832E85E9283

Q37233253-848D624C-F379-4FAB-B4C7-CA67773FD47F

Q37233253-88DB0666-09FB-4B81-9615-59C0BA90F607

Q37233253-8CD6C94C-2F76-4C81-869D-4A39040B4A88

P304

Q37233253-ECC9DC53-5733-4B3D-881E-6A336506FCB1

P31

Q37233253-EB17D01B-BBD8-41D6-BA31-B694EC235D99

P356

Q37233253-1ABBBF8E-0B86-4685-88B7-BDE0DFAB09FE

P407

Q37233253-88A07932-DA58-4B1B-873F-24AA446BF45A

P433

Q37233253-1EE48748-A9D8-4350-83D7-E99FF0E832DB

P478

Q37233253-55F4F149-EC30-4B7C-B85B-6BC2D2EBDBD0

P577

Q37233253-361CED01-E4DF-44BE-BAD1-DBF5B9F7FC23

P698

Q37233253-5E7820B1-5B07-44D9-8A3F-9D5347E21325

P921

Q37233253-FBC59445-F431-4507-9B72-76D2449FD8D5

P932

Q37233253-C06C53EC-B6A4-492F-A497-477A7C1D2061

P356

P1433

Clinical Ophthalmology

P1476

Development of ocular hyperten ...... al injection of triamcinolone.

@en

P2093

Cemil Yilmazli

http://www.w3.org/2001/XMLSchema#string

Gokhan Gulkilik

http://www.w3.org/2001/XMLSchema#string

M Selim Kocabora

http://www.w3.org/2001/XMLSchema#string

Muhittin Taskapili

http://www.w3.org/2001/XMLSchema#string

Sahan Durmaz

http://www.w3.org/2001/XMLSchema#string

P2860

Systemic hypertension and glaucoma: mechanisms in common and co-occurrence

The effect of intravitreal triamcinolone acetonide on intraocular pressure.

Argon laser trabeculoplasty for intractable glaucoma following intravitreal triamcinolone.

Intravitreal triamcinolone for refractory diabetic macular edema: two-year results of a double-masked, placebo-controlled, randomized clinical trial.

Selective laser trabeculoplasty for intraocular pressure elevation after intravitreal triamcinolone acetonide injection.

[Treatment of diabetic macular edema with intravitreal triamcinolone acetonide injection: functional and anatomical outcomes]

Steroid-induced glaucoma: A. Persistent elevation of intraocular pressure B. Histopathological aspects.

Intravitreal triamcinolone acetonide for treatment of intraocular proliferative, exudative, and neovascular diseases.

Intravitreal triamcinolone acetonide for treatment of intraocular oedematous and neovascular diseases.

Severe steroid-induced glaucoma following intravitreal injection of triamcinolone acetonide.

P304

167-171

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/OPTH.S2359

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

2

http://www.w3.org/2001/XMLSchema#string

P577

2008-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19668401

http://www.w3.org/2001/XMLSchema#string

P921

arterial hypertension

P932

2698684

http://www.w3.org/2001/XMLSchema#string